Cite
HARVARD Citation
Grimmer, T. et al. (n.d.). P06 Concordance of florbetapir (18F) PET and Elecsys® β-Amyloid(1–42) CSF immunoassay in the CREAD (BN29552) study of crenezumab in prodromal-to-mild AD. Clinical neurophysiology. 130 (8), pp. e148-e149. [Online].